Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -181.99% | 3.14% | -12.94% | 60.99% | 170.98% |
| Total Depreciation and Amortization | 8.47% | 29.75% | 29.44% | 29.90% | 33.73% |
| Total Amortization of Deferred Charges | 25.53% | 41.38% | 93.75% | 62.90% | 4,600.00% |
| Total Other Non-Cash Items | 61.90% | 62.73% | -50.82% | 7.51% | 91.25% |
| Change in Net Operating Assets | -444.88% | -265.68% | 116.51% | -147.03% | 90.67% |
| Cash from Operations | -382.43% | -105.96% | 81.80% | 43.57% | 113.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -66.33% |
| Total Debt Repaid | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -13.10% | 1,766.93% | 432.26% | 157.91% | 36.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | 86.84% |
| Cash from Financing | -48.90% | 2,493.88% | -96.72% | 119.73% | -44.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.20% | 420.81% | -435.86% | 122.62% | -180.15% |